Animal Regenerative Therapies Market to Hit $870M by 2032 as Biotech Scales
The global animal regenerative therapies market is projected to reach $870 million by 2032, fueled by breakthroughs in stem cell and PRP treatments. This growth reflects a broader venture shift toward high-margin veterinary biotechnology as pet owners demand human-grade medical outcomes for companion animals.